Cardiac Raynaud's phenomenon induced by cold provocation as a predictor of long-term left ventricular dysfunction and remodelling in systemic sclerosis: 7-year follow-up study

European Journal of Heart Failure

Volumn 12, Issue 3, 2010, Pages 268-275

  Mizuno, Reiko ^a   Fujimoto, Shinichi ^a   Saito, Yoshihiko ^a   Nakamura, Shinobu ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cardiac Raynaud's phenomenon; Systemic sclerosis; Ventricular dysfunction; Ventricular remodelling

Indexed keywords

ADULT; ARTICLE; COLD; COMORBIDITY; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; RAYNAUD PHENOMENON; SYSTEMIC SCLEROSIS;

ANALYSIS OF VARIANCE; COLD TEMPERATURE; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PROGNOSIS; PROSPECTIVE STUDIES; RAYNAUD DISEASE; RISK FACTORS; SCLERODERMA, SYSTEMIC; STROKE VOLUME; SYSTOLE; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77249142277     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp198     Document Type: Article

References (38)

1. Masi AT. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23: 581-590.
2. Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner HN Jr, Brinker JA, Ciuffo AA, Becker LC. Reversible cold-induced abnormalities in myo-cardial perfusion and function in systemic sclerosis. Ann Intern Med 1986;105: 661-668.
3. Gustafsson R, Mannting F, Kazzam E, Waldenstrom A, Hallgren R. Cold-induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989;2:475-479.
4. Shea MJ, Deanfield JE, deLandsheere CM, Wilson RA, Kensett M, Selwyn AP. Asymptomatic myocardial ischemia following cold provocation. Am Heart J 1987;114:469-476.
5. Long A, Duffy G, Bresnihan B. Reversible myocardial perfusion defects during cold challenge in scleroderma. Br J Rheumatol 1986;25:158-161.
6. Ellis WW, Baer AN, Robertson RM, Pincus T, Kronenberg MW. Left ventricular dysfunction induced by cold exposure in patients with systemic sclerosis. Am J Med 1986;80:385-392.
7. Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papazoglou S, Papamichael C, Moulopoulou D, Kostamis P, Stamatelopoulos S, Moulopoulos S. Cold-induced coronary Raynaud's phenomenon in patients with systemic sclerosis. Clin Exp Rheumatol 1998;16:135-140.
8. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets and patho-genesis. J Rheumatol 1988;15:202-205.
9. Hayat SA, Dwivedi G, Jacobsen A, Lim TK, Kinsey C, Senior R. Effects of left bundle-branch block on cardiac structure, function, perfusion, and perfusion reserve: implications for myocardial contrast echocardiography versus radio-nuclide perfusion imaging for the detection of coronary artery disease. Circulation 2008;117:1832-1841.
10. Vogel R, Indermühle A, Reinhardt J, Meier P, Siegrist PT, Namdar M, Kaufmann PA, Seiler C. The quantification of absolute myocardial perfusion in humans by contrast echocardiography: algorithm and validation. J Am Coll Cardiol 2005;45:754-762.
11. Wei K, Ragosta M, Thorpe J, Coggins M, Moos S, Kaul S. Noninvasive quantification of coronary blood flow reserve in humans using myocardial contrast echo-cardiography. Circulation 2001;103:2560-2565.
12. Wei K, Jayaweera AR, Firoozan S, Linka A, Skyba DM, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-483.
13. Porter TR, D'Sa A, Turner C, Jones LA, Minisi AJ, Mohanty PK, Vetrovec GW, Nixon JV. Myocardial contrast echocardiography for the assessment of coronary blood flow reserve: validation in humans. J Am Coll Cardiol 1993;21:349-355.
14. Peltier M, Vancraeynest D, Pasquet A, Ay T, Roelants V, D'hondt AM, Melin JA, Vanoverschelde JL. Assessment of the physiologic significance of coronary disease with dipyridamole real-time myocardial contrast echocardiography. Comparison with technetium-99 m sestamibi single-photon emission computed tomography and quantitative coronary angiography. J Am Coll Cardiol 2004;43: 257-264. (Pubitemid 38201153)
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
16. Cheitlin MD, Alpert JS, Armstrong WF, Aurigemma GP, Beller GA, Bierman FZ, Davidson TW, Davis JL, Douglas PS, Gillam LD, ACC/AHA Guidelines for the Clinical Application of Echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. Circulation 1997;95: 1686-1744.
17. Olivotto I, Cecchi F, Gistri R, Lorenzoni R, Chiriatti G, Girolami F, Torricelli F, Camici PG. Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;47:1043-1048.
18. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002;105:595-601.
19. Bolognese L, Neskovic AN, Parodi G, Cerisano G, Buonamici P, Santoro GM, Antoniucci D. Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications. Circulation 2002;106:2351-2357.
20. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creati-nine. Nephron 1976;16:31-41.
21. Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC. The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation. Medicine (Baltimore) 1974;53:1-46.
22. Furst DE, Davis JA, Clements PJ, Chopra SK, Theofilopoulos AN, Chia D. Abnormalities of pulmonary vascular dynamics and inflammation in early progressive systemic sclerosis. Arthritis Rheum 1981;24:1403-1408.
23. Ferraccioli G, Di Poi E, Di Gregorio F, Giacomuzzi F, Guerra U. Changes in regional cerebral blood flow after a cold hand test in systemic lupus erythemato-sus patients with Raynaud's syndrome. Lancet 1999;354:2135-2136.
24. Vignaux O, Allanore Y, Meune C, Pascal O, Duboc D, Weber S, Legmann P, Kahan A. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac magnetic resonance imaging and tissue Doppler echo-cardiography in systemic sclerosis. Ann Rheum Dis 2005;64:1268-1273.
25. Geirsson AJ, Danielsen R, Pétursson E. Left ventricular myocardial perfusion and function in systemic sclerosis before and after diltiazem treatment. Scand J Rheu-matol 1996;25:317-320.
26. Lekakis J, Mavrikakis M, Emmanuel M, Prassopoulos V, Papamichael C, Moulopoulou D, Ziaga A, Kostamis P, Moulopoulos S. Acute estrogen administration can reverse cold-induced coronary Raynaud's phenomenon in systemic sclerosis. Clin Exp Rheumatol 1996;14:421-424.
27. Allanore Y, Meune C, Vignaux O, Weber S, Legmann P, Kahan A. Bosentan increases myocardial perfusion and function in systemic sclerosis: a magnetic resonance imaging and Tissue-Doppler echography study. J Rheumatol 2006;33: 2464-2469.
28. Weiss S, Stead EA, Warren JV, Bailey OT. Scleroderma heart disease: with a consideration of certain other visceral manifestations of scleroderma. Arch Intern Med 1943;71:749-776.
29. Follansbee WP, Curtiss EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR, Rodnan GP. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984;310:142-148.
30. Follansbee WP, Zerbe TR, Medsger TA Jr. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993;125: 194-203.
31. Valentini G, Vitale DF, Giunta A, Maione S, Gerundo G, Arnese M, Tirri E, Pelaggi N, Giacummo A, Tirri G, Condorelli M. Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996;55:455-460.
32. Kazzam E, Caidahl K, Hallgren R, Gustafsson R, Landelius J, Waldenstrom A. Non-invasive assessment of systolic left ventricular function in systemic sclerosis. Eur Heart J 1991;12:151-156.
33. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: A controlled study of 100 consecutive patients. Arthritis Rheum 2008;58:1803-1809.
34. Mizuno R, Fujimoto S, Nakano H, Nakajima T, Kimura A, Nakagawa Y, Dohi K. Atrial conduction abnormalities in patients with systemic progressive sclerosis. Eur Heart J 1997;18:1995-2001.
35. Mizuno R, Fujimoto S, Nakano H, Nakajima T, Kimura A, Nakagawa Y, Dohi K. Atrial involvement in patients with progressive systemic sclerosis: relationship between ultrasonic tissue characterization of the atrium and interatrial conduction. Cardiology 1999;91:134-139.
36. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Circulation 1976;53: 483-490.
37. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, Gialafos EJ, Moyssakis I, Moutsopoulos HM. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007;56:3827-3836.
38. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006;45:14-17.